DataMEDS AI Inc.
MEDS | NASDAQ
$2.00
+$0.08 (+4.17%)
Nov 2, 2026, 10:10 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 23.34M | 18.13M | n/a | 32.78M |
Cost of Revenue | 32.98M | 16.36M | n/a | 27.03M |
Gross Profit | -9.64M | 1.77M | n/a | 5.75M |
Operating Income | -81.19M | -6.15M | -2.88M | -3.42M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -101.27M | -6.86M | -2.9M | -2.74M |
Net Income | -101.27M | -6.86M | -2.9M | -2.74M |
Selling & General & Admin | 71.56M | 6.8M | 2.88M | 7.08M |
Research & Development | n/a | n/a | 375 | 1.4K |
Other Expenses | n/a | 1.11M | -375 | 2.09M |
Operating Expenses | 71.56M | 7.91M | 2.88M | 9.17M |
Interest Expense | 4.58M | 831.47K | 15.08K | 287.18K |
Selling & Marketing Expenses | 1.22M | n/a | n/a | n/a |
Cost & Expenses | 104.53M | 24.27M | 2.88M | 36.2M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.42M | 1.04M | 894.4K | 945.04K |
Shares Outstanding (Diluted) | 1.42M | 1.04M | 894.4K | 945.04K |
EPS (Basic) | -71.50 | -6.50 | -3 | -2.90 |
EPS (Diluted) | -71.50 | -6.50 | -3 | -2.90 |
EBITDA | -93.48M | -4.91M | -2.88M | -369.03K |
EBIT | -96.69M | -6.02M | -2.88M | -2.46M |
Depreciation & Amortization | 3.21M | 1.11M | n/a | 2.09M |
Add to Watchlist
Select watchlists to add or remove MEDS